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ABSTRACT
Objective: To evaluate the feasibility of integrating robot-
assisted technology in the performance of laparoscopic
staging of gynecologic malignancies.
Methods: Seven patients underwent robot-assisted laparo-
scopic staging procedures for gynecologic cancers. Data
were collected and analyzed as a retrospective case series
analysis.
Results: We attempted 7 robot-assisted laparoscopic staging
procedures with no conversions to laparotomy. The median
lymph node count for lymphadenectomy was 15 (range, 4 to
29). Mean operating time was 257 minutes (range, 174 to
345). The average estimated blood loss was 50 mL. One
patient developed sinusitis and required intravenous antibi-
otics. The median hospital stay was 2 days.
Conclusion: Robot-assisted laparoscopic staging is a fea-
sible technique that may overcome the surgical limitations
of conventional laparoscopy.
Key Words: Robot-assisted laparoscopy, Cancer staging,
Gynecologic cancer, Surgical technique.
INTRODUCTION
Historically, gynecologic cancers have been treated with
multimodal therapy including radical surgery combined with
radiation and chemotherapy based on the stage and type of
disease. Although this approach has resulted in a substantial
improvement in outcomes, it has come at the cost of signif-
icant patient morbidity. In the last 15 years, laparoscopic
approaches for many gynecologic surgical procedures for
cancer have been developed, resulting in a reduction in
postoperative morbidity and emerging evidence of out-
comes that appear to match those of laparotomy. Complete
staging procedures including abdominal exploration, hyster-
ectomy, pelvic and para-aortic lymphadenectomy, omentec-
tomy, and peritoneal biopsies can be performed in a mini-
mally invasive setting with laparoscopy.1–3
Limitations to the conventional laparoscopic approach to
gynecologic oncology surgery include lack of depth per-
ception due to 2-dimensional imaging, instruments with
limited range of motion, poor ergonomics for the surgical
team including unstable camera images and awkward
operating positions, and a lengthy training interval to
attain laparoscopic competence. Despite these pitfalls, a
number of manuscripts have been published demonstrat-
ing the feasibility and applicability of the laparoscopic
approach to gynecologic oncology surgery.
The da Vinci telerobotic laparoscopic system is an innovative
technology that addresses many of the current limitations of
laparoscopy, including development of a 3-dimensional vi-
sion system for the surgeon, and laparoscopic instruments
with a wrist-like mechanism, allowing full replication of the
range of motion of the surgeon’s hand with an 8-mm instru-
ment. The da Vinci Robotic Surgical System (Intuitive Surgi-
cal, Inc. Sunnyvale, CA) is composed of 3 components (Fig-
ure 1). The first component is the surgeon’s console, located
away from the patient bedside. The surgeon sits at the sur-
geon’s console and uses a stereoscopic viewer in addition to
hand manipulators (“masters”) and foot pedals that translate
coordinated hand and foot movements into identical move-
ment of the instruments within the patient (Figure 2). The
second component of the da Vinci Robotic Surgical System is
the InSite Vision System that provides a 3-dimensional image
through a 12-mm endoscope containing stereoscopic cam-
eras and dual optical channels. The third component of the
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SCIENTIFIC PAPERda Vinci Robotic Surgical System is the patient-side cart with
telerobotic arms and EndoWrist instruments. Currently, this
system is available with either 3 or 4 robotic arms. One of the
arms holds the laparoscope while the other 2 to 3 arms hold
the various laparoscopic surgical instruments. These EndoW-
rist instruments are unique in that they possess a mechanical
wrist that allows 7 degrees of freedom of motion, thereby
replicating the full range of motion of the surgeon’s hand.
Movement is intuitive, and therefore the fulcrum effect seen
with conventional laparoscopy is eliminated. A series of
EndoWrist instruments can be interchanged on either of the
lateral robotic arms.
Recent publications4–9 have illustrated the applicability of
robot-assisted (telerobotic) laparoscopy for heart surgery,
fallopian tube reanastomosis, ovarian transposition, bowel
resection and anastomosis, hysterectomy, and pelvic lymph-
adenectomy. As yet, no publications in the peer review
literature describe the technique and outcomes for many
gynecologic procedures that are currently approached with
conventional laparoscopic instrumentation, such as gyneco-
logic oncology staging procedures, or myomectomy.
In November 2001, the University of Michigan Depart-
ment of Obstetrics and Gynecology began a structured
robot-assisted laparoscopy program. To date, 83 pa-
tients have undergone gynecologic procedures in this
program, including the 7 cancer staging procedures to
be reported here. This report will outline the technique
and initial results of gynecologic oncology staging pro-
cedures using the da Vinci telerobotic laparoscopy sur-
gical system.
METHODS
We performed a review of data collected from the
initiation of our robot-assisted surgery program, after
obtaining approval from our Institutional Review Board
(IRB #2003–0763). All robot-assisted laparoscopic stag-
ing procedures attempted at the University of Michigan
Medical Center between August 2002 and May 2004
were analyzed based on the intent to treat. A robot-
assisted approach was offered to patients with complex
gynecologic pathology. The authors performed all the
procedures.
All patients were placed in the low dorsal lithotomy po-
sition with arms padded and tucked after general anes-
thesia was administered. For patients with an intact uterus,
a RUMI uterine manipulator was placed in conjunction
with a Koh colpotomy ring and vaginal pneumo-occluder
balloon (Figure 3). Four ports were typically used after
pneumoperitoneum was obtained. A 12-mm camera port
Figure 1. Photograph of the da Vinci Robotic Surgical System. From left to right: surgeon’s console, patient-side surgical cart, and InSite
vision tower. Photo courtesy of Intuitive Surgical.
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on the size of the uterus (Figure 4). Two 8-mm ports that
mount directly to the operating arms on the patient-side
cart were placed in the left and right lower quadrants,
respectively. A fourth port served as an accessory port and
was placed between the camera port and the right lower
quadrant port. This was typically a 12-mm port to facilitate
introduction of suture and instruments for assisting with
exposure in addition to specimen removal.
Once all 4 ports were in place, the patient was placed in
a steep Trendelenburg position, and the patient-side cart
was brought between the patient’s legs and docked,
meaning that each port was attached to the assigned
robotic arm with the exception of the accessory port. The
assisting surgeon, at the right side of the patient, was
responsible for EndoWrist instrument exchanges and for
use of the assist port to aid in traction and exposure or
removal of specimens. EndoWrist instruments used in-
cluded Cadiere (fenestrated) forceps, DeBakey forceps,
round-tip scissors, needle driver, monopolar electrocau-
tery using a hook tip, and bipolar cautery forceps.
A survey of the operative field was performed and wash-
ings were obtained. The retroperitoneum was opened by
incising lateral and parallel to the infundibulopelvic liga-
ment from the pelvic brim to the round ligament. Perito-
neal edges were elevated and underlying connective tis-
sues were bluntly separated with careful opposing
traction parallel to the vessels to open the retroperitoneal
space by using the Cadiere and monopolar hook instru-
ments. Once pelvic vessels and ureters were identified,
lymph nodes were isolated and removed by incising tis-
sues lateral and parallel to the external iliac artery extend-
ing from the bifurcation of the common iliac artery to the
crossover of the deep circumflex iliac vein over the exter-
nal iliac artery. The lymphatic bundle was retracted me-
dially and dissected from the external iliac artery and vein.
The obturator space was exposed by lateral retraction of
the external iliac vein and lymphatic tissues were dis-
sected free from posterior attachment to the external iliac
vein and lateral attachment to the pelvic sidewall. Care
was taken to identify the obturator nerve, which was
stripped free of attachment to the lymphatic tissues. Com-
mon iliac and para-aortic nodes up to the level of the
inferior mesenteric artery were obtained with the same
port and patient-side cart placements. It was rarely nec-
essary to change to different EndoWrist instruments dur-
ing the lymphadenectomy. Common iliac nodes were
obtained by extending the peritoneal incision above the
pelvic brim and reflecting the peritoneum medially to
expose the common iliac vessels. Low para-aortic nodes
were obtained by incising peritoneum over the right com-
mon iliac artery and extending along the aorta.
Paraaortic nodes above the inferior mesenteric artery are
difficult to obtain without redocking the patient-side cart
due to limitation in the range of motion of the joints in the
robotic arms. To attain high para-aortic nodes, the patient-
side cart is undocked from the patient, and the operating
room table is rotated 180 degrees such that the surgical
tower is brought in over the patient’s head and shoulders.
The robot is redocked to the existing ports for para-aortic
access. Alternatively, the upper para-aortic nodes can be
removed by undocking the robot and using the laparo-
scope and ports in a conventional laparoscopic approach.
The approach to hysterectomy was consistent with the
American Association of Gynecologic Laparoscopists
(AAGL) type IVE laparoscopic hysterectomy.10 The tech-
nique for hysterectomy included division of the round
Figure 2. Photograph of the da Vinci master controls showing
translation of surgeon hand movement to the EndoWrist instru-
ments attached to the robotic arms. Photo courtesy of Intuitive
Surgical.
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the vessico-uterine fold was incised using the monopolar
hook after elevating peritoneum and using the uterine
manipulator to deflect the uterus. Infundibulopelvic liga-
ments were doubly ligated with 0-Vicryl suture tied intra-
corporeally with the EndoWrist DeBakey and needle
driver. Uterine arteries were skeletonized by using the
monopolar hook and countertraction. The uterine vessels
were then suture ligated using 0-Vicryl suture placed us-
ing the EndoWrist needle driver. The monopolar hook
was utilized to develop the colpotomy incision overlying
the Koh colpotomy ring. The vaginal vault was closed
with interrupted figure of eight stitches made by using
0-Vicryl suture on CT-2 needles.
In cases where omentectomy was required for staging, the
omentum was placed on gentle traction, elevating from the
transverse colon, and the underlying vascular tissues were
divided using EndoWrist harmonic shears, which, unlike the
other EndoWrist instruments, have 4 degrees of freedom
rather than 7 degrees of freedom, resulting in a decreased
ability to manipulate the instrument optimally. The omentum
was cut into strips for removal through the accessory port.
Upon completion of the staging procedure, the pelvis was
irrigated, and a low pressure check was performed to
ensure hemostasis. The patient-side cart was undocked.
All ports larger than 8 mm in diameter were closed with
interrupted 0-Vicryl suture on the fascia.
RESULTS
To date, we have completed 7 procedures with no con-
versions to laparotomy. Four patients underwent a total
laparoscopic hysterectomy (AAGL type IVE) and 2 pa-
tients previously had undergone hysterectomy for various
indications. One of the 4 patients who underwent laparo-
scopic hysterectomies had undergone a recent da Vinci
robot-assisted procedure performed for a benign indica-
tion after which an occult fallopian tube carcinoma was
detected. She underwent a second da Vinci robot-assisted
procedure for staging that is reported in this series as
patient #2 (Tables 1 and 2). Four patients underwent
staging for endometrial cancer: 2 were staged for ovarian
cancer, and 1 was staged for fallopian tube cancer. Six
patients underwent pelvic and para-aortic lymphadenec-
Figure 3. RUMI uterine manipulator is used to manipulate the uterus during surgery, and the Koh colpotomy ring is used to provide
an insulated backstop for the colpotomy incision. The vaginal pneumo-occluder balloon maintains the pneumoperitoneum once the
colpotomy incision is made. (Cooper Surgical Inc., Trumbull, CT)
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pling. Omentectomy and peritoneal staging biopsies were
performed for the patients with ovarian and fallopian
cancers. Most of these patients had prior abdominal or
pelvic surgery and were therefore thought to have a sig-
nificantly higher risk for adhesions (Table 1).
The mean age was 47.6 years (range, 42 to 68). The mean
body mass index was 27 kg/m
2 (range, 22 to 39.6). The
median number of lymph nodes removed in patients un-
dergoing lymphadenectomy was 15 (range, 4 to 29) (Ta-
ble 1). The node count provided by our pathology de-
partment uses only macroscopic lymph nodes with an
identifiable capsule and does not count microscopic
nodes or lymphoid aggregates in the specimen. Figure 5
demonstrates the EndoWrist instruments in use for the
pelvic lymphadenectomy, and Figure 6 illustrates the
level of completeness of the lymphadenectomy.
Estimated blood loss (EBL) was calculated by noting the
difference between the volumes of aspirated and irrigated
fluids. The mean estimated blood loss was 50 mL. No
blood transfusions were administered in our series. The
mean operating time was 257 minutes (range, 174 to 345).
Operative time was counted from the initial examination
with the patient under anesthesia until the dressing was
applied. The median hospital stay for all patients in our
series was 2 days (range, 1 to 6).
Stages determined by robot-assisted staging are listed in
Table 2. All stages were defined by using International
Federation of Gynecology and Obstetrics (FIGO) rules.
Adjuvant therapy, such as radiation or chemotherapy, was
chosen based on tumor type, grade, and stage. All patients
were alive and without evidence of recurrent disease at
the time this series was reported. Duration of follow-up
ranged between 4 months and 25 months (Table 2). One
patient (#5) has subsequently conceived and is nearing
term with a pregnancy that has proceeded normally.
The only complication in this series was sinusitis in 1
patient that developed postoperatively and was felt to be
a complication of anesthesia. The patient required intra-
venous antibiotics for 5 days. No intraabdominal compli-
cations, port-site metastases, or recurrences were noted.
DISCUSSION
Endometrial cancer is the most common gynecologic cancer
in the Unites States. Current staging and surgical treatment of
early-stage endometrial cancer include cytologic washings of
the peritoneum, hysterectomy, and bilateral salpingo-oo-
phorectomy. Selective pelvic and para-aortic lymphadenec-
tomy is usually performed based on risk factors, such as
tumor grade and depth of myometrial invasion. A recent
study by Eltabbakh2 reports on 90 women with clinical stage
I disease. In this series, 90% of patients underwent complete
laparoscopic staging. Among women who underwent lapa-
roscopy, 5.8% required conversion to laparotomy. The au-
thors found that laparoscopic patients had significantly
smaller body mass indices, longer surgical times, more pelvic
lymph nodes retrieved, a smaller change in postoperative
hematocrit, lower pain medication requirements, and shorter
hospital stays compared with patients who had the same
Figure 4. Port Placement. (A) The 12-mm camera port was
placed in the umbilicus or above, depending on the size of the
uterus. (B) The 8-mm lateral ports for robotic instruments mount
directly to the robotic arms and were placed 2 cm to 3 cm medial
and superior to the anterior superior ileac spine with modifica-
tion based on size of the uterus. (C) The assist port was placed
between the camera port and the right lower quadrant port. This
was typically a 12-mm port, used to facilitate introduction of
suture and suction/irrigation instruments.
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tive comparison of laparoscopy versus laparotomy for treat-
ment of 70 women with endometrial cancer revealed no
difference in recurrence rate or duration of survival.11 The
power of the study was low due to the small sample size of
the 2 groups. The Gynecologic Oncology Group is currently
accruing patients into a large phase III, randomized trial of
laparoscopic versus laparotomy surgery for endometrial car-
cinoma. The primary objectives of this study are to compare
complications, length of stay, quality of life, and cancer
outcome.
Ovarian cancer is the deadliest gynecologic malignancy.
The accepted approach for treatment of ovarian cancer is
surgical staging and debulking followed in most cases by
adjuvant chemotherapy based on tumor type and stage of
disease. Epithelial ovarian cancers are the most common
type, with malignant germ cell and stromal tumors each
Table 2.
Postoperative Data
Patient Cancer Type Grade* FIGO Stage Adjuvant Therapy Disease Status* Follow Up (mos.)
1 Endometrial 2 IB None NED 25
2 Fallopian tube 2 IA Carboplatin-paclitaxel chemo, 3
cycles
NED 21
3 Endometrial 3 IA None NED 17
4 Endometrial 3 IIIA Pelvic radiotherapy, 4500 cGy NED 14
5 Ovarian LMP IC None NED 12
6 Ovarian 3 IV Carboplatin-paclitaxel chemo, 3
cycles preop and 3 cycles
postop
NED 7
7 Endometrial 2 IB None NED 4
*LMPovarian tumor of low malignant potential; NEDno evidence of disease.
Table 1.
Preoperative and Intraoperative Data
Patient Cancer Type Prior Pelvic Surgery* Robotic Procedure* Node Count
1 Endometrial Appendectomy, distant past.
Abdominal hysterectomy 6 weeks prior
BSO, PLN 5
2 Fallopian tube da Vinci TLH 2 weeks prior PLN, PAN, omentectomy,
peritoneal biopsies
17
3 Endometrial Abdominal hysterectomy, bilateral
salpingo-oophorectomy 10 weeks
prior
PLN 4
4 Endometrial Appendectomy, distant past TLH, BSO, PLN, PAN, peritoneal
biopsies
29
5 Ovarian Right ovarian cystectomy, 8 weeks prior Right oophorectomy, right
PLNS, omentectomy,
peritoneal biopsies
1
6 Ovarian None TLH, BSO, PLN, PAN,
omentectomy, peritoneal
biopsies
15
7 Endometrial None TLH, BSO, PLN, PAN 18
*BSObilateral salpingo-oophorectomy; PLNpelvic lymphadenectomy; PLNSpelvic lymph node sampling; PANparaaortic lymph-
adenectomy; TLHtotal laparoscopic hysterectomy, AAGL Class IV-E.
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most common in perimenopausal women and are most
often detected in advanced stages, whereas germ cell and
stromal malignancies are usually unilateral and occur pre-
dominately in young, reproductive-age women. These
variations of natural history alter the surgical approach.
For example, a young woman presenting with a unilateral
germ cell malignancy would more likely be treated with a
unilateral salpingo-oophorectomy and staging procedure
with preservation of fertility as an option and would be a
good candidate for laparoscopic staging. On the other
hand, a postmenopausal woman presenting with a dis-
seminated ovarian epithelial carcinoma would require a
radical debulking procedure for which laparoscopy is ill
suited. In the last 13 years, many small, retrospective
series1 have been published, demonstrating the feasibility
of laparoscopic staging for ovarian cancer. In an early
series by Surwit and Childers,12 138 patients underwent
Figure 6. Photographs of the right pelvic lymphadenectomy. In the left frame, an EndoWrist DeBakey is elevating a node from the
underlying ureter and internal iliac artery. In the right frame, the pelvic node dissection has been completed, showing the skeletonized
external iliac artery (1) and vein (2), ischial periosteum (3), anterior division of the hypogastric artery (4), obturator nerve (5),
genitofemoral nerve (6), and psoas muscle (7).
Figure 5. Photographs of retroperitoneal dissection during right pelvic lymphadenectomy. In the left frame, EndoWrist DeBakey and
monoploar hook instruments are used to dissect out the obturator nerve. In the right frame, an EndoWrist bipolar forceps is used to
remove a node bundle from the external iliac vein.
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tection of abdominal and lymphatic metastases was equiv-
alent to historical controls for staging by laparotomy. Eight
percent were converted to laparotomy and 50% were able
to be fully staged laparoscopically. A recent series by
Querleu3 evaluated 30 individuals who underwent lapa-
roscopic staging. All were able to be laparoscopically
staged with a mean operative time of 165 minutes; a 7%
major complication rate and a 2.7-day mean length of stay.
As yet, no, prospective, randomized comparisons of lapa-
roscopy to laparotomy for staging and treatment of ovar-
ian cancer have been published.
Our hypothesis is that two of the most significant reasons
that laparoscopy is not used for more patients with ovar-
ian and endometrial cancer are the relative paucity of
outcomes data as discussed above, in addition to technical
limitations of laparoscopy. The technical limitations can
be patient-specific, or technique-specific. Patient-specific
limitations include issues like obesity, the presence of a
large mass, or ascites. Technique-specific limitations in-
clude lack of depth perception due to 2-dimensional im-
aging; instruments with a limited range of motion due to
fixed, straight shafts with a fulcrum effect; cancer-associ-
ated issues like port-site metastases; and the increased
importance of training and experience for laparoscopy
compared with laparotomy.13 The fulcrum effect, where
the motion of the instrument tip is opposite to the direc-
tion of movement of the operator’s hand, occurs because
the instrument pivots across the fulcrum of the abdominal
wall. Compensation for this counterintuitive motion
lengthens the laparoscopy learning curve.
Obesity is a major impediment to the completion of lapa-
roscopic procedures. Because obesity is one of the major
predisposing risk factors for developing endometrial can-
cer, many patients who ultimately need surgical staging
are well above their ideal body weight. In one study,14 42
women with endometrial cancer and a body mass index
(BMI) 28.0 were offered laparoscopic staging and were
compared with a group of matched controls who under-
went abdominal procedures. The mean BMI for patients
was 35.8. Conversion to laparotomy occurred in 7.5% of
patients. The BMI of patients in this series was as high as
39.6 kg/m
2. No case was converted to laparotomy in this
series. Obesity has thus far not proven to be a contrain-
dication to robot-assisted laparoscopic staging.
Although no absolute upper limit exists for the size of the
mass for laparoscopy, laparotomy is indicated if the size
and position of the mass precludes safe placement of
ports. Masses with a significant solid component or mul-
tiple septations are not amenable to removal through a
laparoscopic port because they cannot be readily reduced
in size without likely spillage into the peritoneal cavity. No
patient in this series had a large or predominantly solid
mass, ascites, or fixation to adjacent organs. Port-site me-
tastasis is reported to occur in 1% to 2% of cases and may
be associated with implantations caused by surgical tech-
nique; positive intraabdominal pressure, causing leakage
around port sites (chimney effect); and pneumoperito-
neum effects on local immune reactions and tumor cells.15
None of the patients reported in this series has had a
port-site metastasis.
Qualifications of the surgeon are critical for all laparoscopic
staging procedures. First, it is well documented that opera-
tive laparoscopy has a lengthy learning curve before com-
petence is high and complication rates are reduced. Training
and credentialing for advanced operative laparoscopy
should be a high priority to maximize patient safety. Second,
several published reports document increased accuracy of
surgical staging, increased likelihood of optimal debulking,
and prolongation of survival for ovarian cancer patients who
are staged by a gynecologic oncologist. This resulted in a
recommendation by the National Cancer Institute that
women with masses having a significant risk of malignancy
should be given the opportunity to have surgery performed
by a gynecologic oncologist.16
Despite improvements in endoscopic technology and in-
creasing application of the laparoscopic approach, lapa-
roscopic hysterectomy procedures remain in the minority
of all hysterectomies performed. One reason is the lack of
laparoscopic surgical training of gynecologic surgeons.17
A report18 on the rate of laparoscopic hysterectomy in 23
French medical centers revealed that only 9 centers car-
ried out total laparoscopic hysterectomies and that train-
ing was found to be a major factor in the choice of
technique. When access to surgical training is available,
the learning curve for conventional laparoscopy and pre-
vention of associated complications are still significant
limitations to widespread application. Although no abso-
lute contraindications exist for laparoscopic hysterectomy
and staging, a surgeon’s experience and the pathology
encountered remain the limiting factors for performing
laparoscopic hysterectomy. A recent publication from Fin-
land19 revealed an equivalent complication rate for lapa-
roscopic hysterectomy compared with abdominal hyster-
ectomy, once the surgeon passes a learning threshold of
the first 30 procedures. In a prospective, randomized
Italian study,20 it was shown that total laparoscopic hys-
terectomy could be effectively performed within reason-
able time limits and that operating times are comparable
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erators are experienced surgeons.
Robot-assisted laparoscopy addresses many of the limita-
tions of conventional laparoscopy. The strengths of the da
Vinci Robotic Surgical System include 3-dimensional
depth perception for the operating surgeon and coordi-
nated, complex movements of the EndoWrist instruments
that mimic the surgeon’s hands. Tasks like instrument
tying and suturing can be performed with the same fluid-
ity, ease, and rapidity of an open surgical procedure.
The use of robotic technology to facilitate laparoscopic pro-
cedures has increased dramatically. In numerous studies, it
has been shown to be a safe and effective alternative to
conventional laparoscopic surgery in a variety of surgical
disciplines. In the gynecology literature, reports5,6 exist of
robot-assisted laparoscopy for tubal reanastomosis and hys-
terectomy. One of our hypotheses is that the use of robot-
assisted laparoscopy may rapidly bridge the gap between
assimilation of technique and the actual application of the
procedure. A recent study21 confirmed this principle: the
impact of robotics on surgical skills was assessed by com-
paring conventional laparoscopy with the da Vinci Robotic
Surgical System in the performance of 4 training drills. Sur-
geons completed drills faster with the robotic system. Most
importantly, the study concluded that the “playing field”
between novice and expert laparoscopic surgeons was lev-
eled with the use of the robotic system.21
The cases in our series could have been completed by
conventional laparoscopy, but we believe completion of
these complex cases was facilitated by the robotic system.
This was especially true in cases where patients had previ-
ously undergone several pelvic surgeries. As seen in Table
1, 4 of the 7 patients had one or more prior pelvic surgical
procedures that resulted in scarring or partial obliteration of
the cul de sac in all 4 patients. The mechanical-wrist instru-
ments of the da Vinci Surgical System allowed improved
dexterity that readily overcame these difficulties.
A limitation of the system in its current form is the lack of
tactile feedback for the operating surgeon. Consequently,
it is easy to break sutures or to apply excessive force to
tissues until the operating surgeon learns to recognize
force applied by visual cues, such as tissue blanching or
deflection of soft tissue structures. In addition, the assis-
tant does not have the advantage of a 3-dimensional view
and must work around bulky equipment when the robotic
surgical tower is docked. As technology evolves, this issue
will need to be addressed.
Operative times were much longer than those reported in
most published studies of conventional laparoscopic staging.
This can be broken down into several areas for analysis and
discussion. First, we measured operative time starting with
the examination with the patient under anesthesia rather
than only the time for use of the robot. We felt this was the
most realistic method for estimation of operating room time
and resources. Second, published reports do not use a stan-
dardized definition of operative time, and many authors
report only the laparoscopic time. The operative times re-
ported in this manuscript are therefore longer than times in
many other reports because of this definition. In our institu-
tion, a comparison of laparoscopic staging of gynecologic
malignancies by using conventional laparoscopic technol-
ogy versus robot-assisted staging reveals less than 30 addi-
tional minutes for robot-assisted procedures (unpublished
data). We expect to see substantial improvement as our
experience increases.3 Despite longer operative times with
the robot-assisted approach, the length of hospital stay was
comparable to that reported for other studies of laparoscopic
staging procedures and better than those for abdominal
staging procedures. Blood loss in this series was minimal,
and no transfusions were needed.
Lymph node count in our institution is based on identify-
ing macroscopic nodes with a discreet capsule rather than
microscopic nodes or lymphoid aggregates without a cap-
sule. The surgical procedure performed at our institution
is complete lymphadenectomy rather than lymph node
sampling, regardless of surgical approach (laparotomy
versus conventional laparoscopy versus robot-assisted
laparoscopy). Figure 6 illustrates the completeness of
dissection. No differences existed between lymph node
count as a function of the surgical approach at our insti-
tution (unpublished data).
One patient in this series had a postoperative complica-
tion. She developed sinusitis thought to be due to her
anesthetic. She required intravenous antibiotics for 5 days
following surgery. This complication was not felt to be
attributable to the use of a robot-assist device. No intra-
abdominal complications occurred.
A frequent criticism of laparoscopic surgery is the high
surgical cost due to prolonged operative time, complex
equipment, and expensive disposable instruments. Spir-
tos22 compared cost and quality of life associated with
surgical treatment of early stage endometrial cancers
treated with laparoscopy versus laparotomy in 30 women.
Patients undergoing laparoscopy had higher operating
room and anesthesia costs but were noted to have a
significant reduction in their overall medical costs
($13,809 compared to $19,158) and improved quality of
JSLS (2005)9:149–158 157life. The cost of using a robot-assist device is substantially
higher than the cost of conventional laparoscopy. We are
tracking cost data, but will need a substantially larger
series to provide a comparison of benefit versus cost.
CONCLUSION
This is the first series to report technique and outcome for
robot-assisted laparoscopic staging of gynecologic malig-
nancies. Based on our early experience, the use of robot-
assisted technology like the da Vinci Surgical System is
feasible for total hysterectomy and staging of gynecologic
malignancies. As our experience evolves, a more accurate
comparison of robot-assisted to conventional laparo-
scopic staging outcomes can be developed to assess rel-
ative advantages and disadvantages of this new technol-
ogy. The evolving literature on robot-assisted surgery
suggests that surgical limitations of conventional laparos-
copy can be overcome and that the skill level of the
surgeon may be enhanced independently of prior laparo-
scopic experience. Although the first-generation da Vinci
Robotic Surgical System provides improved imaging and
instrumentation, the absence of tactile feedback and the
high cost of the technology remain limitations. Future
areas of study will include improvement of technique, and
evaluation of robotic technology on surgical training and
competence, in addition to development of cost reduction
strategies.
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